obesity drugs

    By Melly Alazraki

    | 9:00AM 9/02/2010
    Orexigen jumped over 25% in premarket trading after announcing an exclusive partnership agreement potentially worth over $1 billion with Japan's Takeda Pharmaceutical to develop and commercialize Contrave, Orexigen's promising obesity drug.

    By Eric Wahlgren

    | 12:00PM 9/20/2009
    Among weight loss pills, the Holy Grail is a drug that is safe and really zaps the fat. As of now, the search is still on. Obesity drug lorcaserin got the safety part down: results from a very large trial -- 4,008 patients -- didn't appear to show the heart valve problems associated with some...